Literature DB >> 14991088

Excessive antimicrobial usage causes measurable harm to patients with suspected ventilator-associated pneumonia.

Victor L Yu, Nina Singh.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 14991088     DOI： 10.1007/s00134-004-2201-0

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN： 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  14 in total

1.  Resolution of infectious parameters after antimicrobial therapy in patients with ventilator-associated pneumonia.

Authors:  P J Dennesen; A J van der Ven; A G Kessels; G Ramsay; M J Bonten
Journal:  Am J Respir Crit Care Med       Date:  2001-05       Impact factor: 21.405

Review 2.  Appropriate antibiotic therapy for ventilator-associated pneumonia and sepsis: a necessity, not an issue for debate.

Authors:  Marin H Kolleff
Journal:  Intensive Care Med       Date:  2003-02       Impact factor: 17.440

3.  Outcome of postoperative pneumonia in the Eole study.

Authors:  Hervé Dupont; Philippe Montravers; Rémy Gauzit; Benoît Veber; Jean-Louis Pouriat; Claude Martin
Journal:  Intensive Care Med       Date:  2003-01-14       Impact factor: 17.440

4.  Ventilator-associated pneumonia: is there any gold in these standards?

Authors:  Kenneth D Chinsky
Journal:  Chest       Date:  2002-12       Impact factor: 9.410

5.  Diagnosing pneumonia during mechanical ventilation: the clinical pulmonary infection score revisited.

Authors:  Muriel Fartoukh; Bernard Maitre; Stephanie Honoré; Charles Cerf; Jean-Ralph Zahar; Christian Brun-Buisson
Journal:  Am J Respir Crit Care Med       Date:  2003-05-08       Impact factor: 21.405

6.  Indications for antibiotic use in ICU patients: a one-year prospective surveillance.

Authors:  D C Bergmans; M J Bonten; C A Gaillard; F H van Tiel; S van der Geest; P W de Leeuw; E E Stobberingh
Journal:  J Antimicrob Chemother       Date:  1997-04       Impact factor: 5.790

7.  Resolution of ventilator-associated pneumonia: prospective evaluation of the clinical pulmonary infection score as an early clinical predictor of outcome.

Authors:  Carlos M Luna; Daniel Blanzaco; Michael S Niederman; Walter Matarucco; Natalio C Baredes; Pablo Desmery; Fernando Palizas; Guillermo Menga; Fernando Rios; Carlos Apezteguia
Journal:  Crit Care Med       Date:  2003-03       Impact factor: 7.598

8.  Diagnosis of ventilator-associated pneumonia by bacteriologic analysis of bronchoscopic and nonbronchoscopic "blind" bronchoalveolar lavage fluid.

Authors:  J Pugin; R Auckenthaler; N Mili; J P Janssens; P D Lew; P M Suter
Journal:  Am Rev Respir Dis       Date:  1991-05

9.  Invasive and noninvasive strategies for management of suspected ventilator-associated pneumonia. A randomized trial.

Authors:  J Y Fagon; J Chastre; M Wolff; C Gervais; S Parer-Aubas; F Stéphan; T Similowski; A Mercat; J L Diehl; J P Sollet; A Tenaillon
Journal:  Ann Intern Med       Date:  2000-04-18       Impact factor: 25.391

10.  Value of the clinical pulmonary infection score for the identification and management of ventilator-associated pneumonia.

Authors:  Charles-Edouard Luyt; Jean Chastre; Jean-Yves Fagon
Journal:  Intensive Care Med       Date:  2004-02-04       Impact factor: 17.440
View more
  15 in total

1.  A new category--healthcare-associated pneumonia: a good idea, but problems with its execution.

Authors:  S Fujitani; V L Yu
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2006-10       Impact factor: 3.267

2.  [Antibiotic treatment of surgical intensive care patients: procalcitonin to guide duration of therapy].

Authors:  M Hochreiter; T Köhler; A-M Schweiger; F S Keck; B Bein; T von Spiegel; S Schröder
Journal:  Anaesthesist       Date:  2008-06       Impact factor: 1.041

3.  Prolonged antibiotic prophylaxis after thoracoabdominal esophagectomy does not reduce the risk of pneumonia in the first 30 days: a retrospective before-and-after analysis.

Authors:  Marcel Hochreiter; Maria Uhling; Leila Sisic; Thomas Bruckner; Alexandra Heininger; Andreas Hohn; Katja Ott; Thomas Schmidt; Marc Moritz Berger; Daniel Christoph Richter; Markus Büchler; Markus Alexander Weigand; Cornelius Johannes Busch
Journal:  Infection       Date:  2018-06-05       Impact factor: 3.553

4.  Critical analysis of empiric antibiotic utilization: establishing benchmarks.

Authors:  Jeffrey A Claridge; Priscilla Pang; William H Leukhardt; Joseph F Golob; Jeffrey W Carter; Adam M Fadlalla
Journal:  Surg Infect (Larchmt)       Date:  2010-04       Impact factor: 2.150

5.  Ertapenem versus cefepime for initial empirical treatment of pneumonia acquired in skilled-care facilities or in hospitals outside the intensive care unit.

Authors:  S V Yakovlev; L S Stratchounski; G L Woods; B Adeyi; K A McCarroll; J A Ginanni; I R Friedland; C A Wood; M J DiNubile
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2006-10       Impact factor: 3.267

6.  Next Steps for Confirming Bronchoalveolar Lavage Amlyase as an Useful Biomarker for Ventilator-Associated Pneumonia.

Authors:  Stephanie Royer; Hallie C Prescott
Journal:  Crit Care Med       Date:  2018-01       Impact factor: 7.598

7.  Procalcitonin (PCT)-guided algorithm reduces length of antibiotic treatment in surgical intensive care patients with severe sepsis: results of a prospective randomized study.

Authors:  S Schroeder; M Hochreiter; T Koehler; A-M Schweiger; B Bein; F S Keck; T von Spiegel
Journal:  Langenbecks Arch Surg       Date:  2008-11-26       Impact factor: 3.445

8.  Antibiotic management of suspected nosocomial ICU-acquired infection: does prolonged empiric therapy improve outcome?

Authors:  Mary-Anne W Aarts; Christian Brun-Buisson; Deborah J Cook; Anand Kumar; Steven Opal; Graeme Rocker; Terry Smith; Jean-Louis Vincent; John C Marshall
Journal:  Intensive Care Med       Date:  2007-06-09       Impact factor: 17.440

9.  Clinical practice guidelines for hospital-acquired pneumonia and ventilator-associated pneumonia in adults.

Authors:  Coleman Rotstein; Gerald Evans; Abraham Born; Ronald Grossman; R Bruce Light; Sheldon Magder; Barrie McTaggart; Karl Weiss; George G Zhanel
Journal:  Can J Infect Dis Med Microbiol       Date:  2008-01       Impact factor: 2.471

10.  Procalcitonin to guide duration of antibiotic therapy in intensive care patients: a randomized prospective controlled trial.

Authors:  Marcel Hochreiter; Thomas Köhler; Anna Maria Schweiger; Fritz Sixtus Keck; Berthold Bein; Tilman von Spiegel; Stefan Schroeder
Journal:  Crit Care       Date:  2009-06-03       Impact factor: 9.097
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.